MetaADEDB 2.0 @ LMMD
Galantamine
(QORVDGQLPPAFRS-XPSHAMGMSA-N)
Structure
SMILES
COc1ccc2c3c1O[C@@H]1[C@@]3(CCN(C2)C)C=C[C@@H](C1)O.Br
Molecular Formula:
C17H22BrNO3
Molecular Weight:
368.265
Log P:
2.7463
Hydrogen Bond Acceptor:
4
Hydrogen Bond Donor:
2
TPSA:
41.93
CAS Number(s):
1953-04-4; 193146-85-9
Synonym(s)
1.
Galantamine
2.
Galantamin
3.
Galanthamine
4.
Lycoremine
5.
Reminyl
6.
Galanthamine Hydrobromide
7.
Nivalin
8.
Nivaline
9.
Razadyne
External Link(s)
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1NauseaFAERS: 47
Canada Vigilance: 12
Canada Vigilance
US FAERS
2VomitingFAERS: 47
Canada Vigilance: 7
Canada Vigilance
US FAERS
3Medication ErrorFAERS: 42
Canada Vigilance: 1
Canada Vigilance
US FAERS
4PneumoniaFAERS: 41
Canada Vigilance: 2
Canada Vigilance
US FAERS
5No adverse eventFAERS: 40US FAERS
6Incorrect dose administeredFAERS: 30US FAERS
7Drug prescribing errorFAERS: 29US FAERS
8DizzinessFAERS: 27
Canada Vigilance: 6
Canada Vigilance
US FAERS
9BradycardiaFAERS: 26
Canada Vigilance: 2
Canada Vigilance
US FAERS
10Inappropriate schedule of drug administrationFAERS: 20US FAERS
11Accidental overdoseFAERS: 18US FAERS
12AgitationFAERS: 18
Canada Vigilance: 1
Canada Vigilance
US FAERS
13Myocardial InfarctionFAERS: 18
Canada Vigilance: 2
Canada Vigilance
US FAERS
14SomnolenceFAERS: 18
Canada Vigilance: 2
Canada Vigilance
US FAERS
15SyncopeFAERS: 18
Canada Vigilance: 4
Canada Vigilance
US FAERS
16MalaiseFAERS: 17
Canada Vigilance: 1
Canada Vigilance
US FAERS
17AstheniaFAERS: 15
Canada Vigilance: 5
Canada Vigilance
US FAERS
18Cerebral InfarctionFAERS: 14US FAERS
19Cerebrovascular accidentFAERS: 14
Canada Vigilance: 6
Canada Vigilance
US FAERS
20DeliriumFAERS: 14
Canada Vigilance: 1
Canada Vigilance
US FAERS
21Drug dose omissionFAERS: 14US FAERS
22OverdoseFAERS: 13US FAERS
23Respiratory arrestFAERS: 13US FAERS
24Weight decreasedFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
25Blood creatine phosphokinase increasedFAERS: 12US FAERS
26HeadacheFAERS: 12
Canada Vigilance: 4
Canada Vigilance
US FAERS
27Altered state of consciousnessFAERS: 10US FAERS
28Pulmonary EmbolismFAERS: 10US FAERS
29DehydrationFAERS: 9US FAERS
30Depressed Level of ConsciousnessFAERS: 9US FAERS
31FractureFAERS: 9US FAERS
32IleusFAERS: 9US FAERS
33MyoclonusFAERS: 9US FAERS
34RestlessnessFAERS: 9
Canada Vigilance: 1
Canada Vigilance
US FAERS
35Wrong technique in drug usage processFAERS: 9US FAERS
36Cardiac ArrestFAERS: 8
Canada Vigilance: 2
Canada Vigilance
US FAERS
37MarasmusFAERS: 8US FAERS
38Respiratory FailureFAERS: 8US FAERS
39Urinary RetentionFAERS: 8US FAERS
40AbasiaFAERS: 7US FAERS
41Abdominal PainFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
42DementiaFAERS: 7
Canada Vigilance: 1
Canada Vigilance
US FAERS
43EpilepsyFAERS: 7US FAERS
44TremorFAERS: 7US FAERS
45AnxietyFAERS: 6
Canada Vigilance: 3
Canada Vigilance
US FAERS
46Atrioventricular BlockFAERS: 6
Canada Vigilance: 2
Canada Vigilance
US FAERS
47PancreatitisFAERS: 6
Canada Vigilance: 1
Canada Vigilance
US FAERS
48Atrial FibrillationFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
49DysuriaFAERS: 5US FAERS
50General physical health deteriorationFAERS: 5
Canada Vigilance: 1
Canada Vigilance
US FAERS
51HypotensionFAERS: 5US FAERS
52Sick Sinus SyndromeFAERS: 5US FAERS
53Transaminases increasedFAERS: 5US FAERS
54UrticariaFAERS: 5US FAERS
55Accidental exposureFAERS: 4US FAERS
56AngerFAERS: 4US FAERS
57AsthmaFAERS: 4US FAERS
58Cerebral atrophyFAERS: 4US FAERS
59Chest PainFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
60CholecystitisFAERS: 4US FAERS
61DisorientationFAERS: 4US FAERS
62DrowningFAERS: 4US FAERS
63Drug administration errorFAERS: 4US FAERS
64Drug dispensing errorFAERS: 4US FAERS
65Feeling abnormalFAERS: 4US FAERS
66Gastric ulcerFAERS: 4US FAERS
67Heat StrokeFAERS: 4US FAERS
68Inappropriate schedule of product administrationFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
69Pharmaceutical product complaintFAERS: 4US FAERS
70RhabdomyolysisFAERS: 4US FAERS
71Sudden deathFAERS: 4US FAERS
72TachycardiaFAERS: 4US FAERS
73Urinary tract infectionFAERS: 4
Canada Vigilance: 1
Canada Vigilance
US FAERS
74Alanine Aminotransferase IncreasedFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
75BradykinesiaFAERS: 3US FAERS
76CardiomegalyFAERS: 3US FAERS
77CataractFAERS: 3US FAERS
78CellulitisFAERS: 3US FAERS
79CholelithiasisFAERS: 3US FAERS
80CholestasisFAERS: 3US FAERS
81ConstipationFAERS: 3US FAERS
82Creatinine renal clearance decreasedFAERS: 3US FAERS
83Cytolytic hepatitisFAERS: 3US FAERS
84DeafnessFAERS: 3US FAERS
85Drug ineffectiveFAERS: 3
Canada Vigilance: 6
Canada Vigilance
US FAERS
86FatigueFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
87Gamma-Glutamyltransferase IncreasedFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
88Gastrointestinal hypomotilityFAERS: 3US FAERS
89GlaucomaFAERS: 3US FAERS
90GoutFAERS: 3US FAERS
91HepatitisFAERS: 3
Canada Vigilance: 1
Canada Vigilance
US FAERS
92HyperthyroidismFAERS: 3US FAERS
93NervousnessFAERS: 3US FAERS
94Neuroleptic Malignant SyndromeFAERS: 3US FAERS
95PetechiaeFAERS: 3US FAERS
96Prescribed overdoseFAERS: 3US FAERS
97Product use in unapproved indicationFAERS: 3US FAERS
98Psychiatric symptomFAERS: 3US FAERS
99SepsisFAERS: 3US FAERS
100Sinus bradycardiaFAERS: 3US FAERS
101TachyarrhythmiaFAERS: 3US FAERS
102ThrombocytopeniaFAERS: 3US FAERS
103TuberculosisFAERS: 3US FAERS
104Wrong technique in product usage processFAERS: 3US FAERS
105Abdominal discomfortFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
106Abdominal tendernessFAERS: 2US FAERS
107Adverse eventFAERS: 2US FAERS
108AscitesFAERS: 2US FAERS
109Aspartate Aminotransferase IncreasedFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
110AtherosclerosisFAERS: 2US FAERS
111Behavioural and psychiatric symptoms of dementiaFAERS: 2US FAERS
112Blood creatinine increasedFAERS: 2US FAERS
113BronchospasmFAERS: 2US FAERS
114CholangitisFAERS: 2US FAERS
115CyanosisFAERS: 2US FAERS
116Deep Vein ThrombosisFAERS: 2US FAERS
117Disease recurrenceFAERS: 2US FAERS
118Drug withdrawal syndromeFAERS: 2US FAERS
119EczemaFAERS: 2US FAERS
120Erectile dysfunctionFAERS: 2US FAERS
121EructationFAERS: 2US FAERS
122ErythemaFAERS: 2US FAERS
123Expired drug administeredFAERS: 2US FAERS
124Feeling ColdFAERS: 2US FAERS
125HepatotoxicityFAERS: 2US FAERS
126Hip surgeryFAERS: 2US FAERS
127Hypertensive crisisFAERS: 2US FAERS
128HyperventilationFAERS: 2US FAERS
129IncontinenceFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
130Incorrect route of drug administrationFAERS: 2US FAERS
131Intentional drug misuseFAERS: 2US FAERS
132LeukopeniaFAERS: 2US FAERS
133MalnutritionFAERS: 2US FAERS
134Memory impairmentFAERS: 2US FAERS
135MeningitisFAERS: 2US FAERS
136Mental status changesFAERS: 2US FAERS
137Mood swingsFAERS: 2US FAERS
138Muscle RigidityFAERS: 2US FAERS
139Musculoskeletal stiffnessFAERS: 2US FAERS
140PoriomaniaFAERS: 2US FAERS
141Product quality issueFAERS: 2US FAERS
142Product use issueFAERS: 2US FAERS
143PruritusFAERS: 2US FAERS
144PurpuraFAERS: 2US FAERS
145PyelonephritisFAERS: 2US FAERS
146ShockFAERS: 2US FAERS
147Therapeutic response unexpectedFAERS: 2US FAERS
148ThrombosisFAERS: 2US FAERS
149UlcerFAERS: 2US FAERS
150Unresponsive to stimuliFAERS: 2US FAERS
151Urinary IncontinenceFAERS: 2
Canada Vigilance: 1
Canada Vigilance
US FAERS
152VertigoFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
153White blood cell count decreasedFAERS: 2US FAERS
154Wrong drug administeredFAERS: 2US FAERS
155jaundiceFAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
156AcidosisFAERS: 1US FAERS
157Activities of daily living impairedFAERS: 1US FAERS
158Acute Coronary SyndromeFAERS: 1US FAERS
159Acute kidney injuryFAERS: 1US FAERS
160Acute myocardial infarctionFAERS: 1US FAERS
161AllodyniaFAERS: 1US FAERS
162AmnesiaFAERS: 1
Canada Vigilance: 2
Canada Vigilance
US FAERS
163Amylase increasedFAERS: 1US FAERS
164Anaphylactic shockFAERS: 1US FAERS
165AneurysmFAERS: 1US FAERS
166AngiodysplasiaFAERS: 1US FAERS
167AngioedemaFAERS: 1US FAERS
168AnorexiaFAERS: 1US FAERS
169Apallic syndromeFAERS: 1US FAERS
170AphagiaFAERS: 1US FAERS
171ArthralgiaFAERS: 1US FAERS
172ArthritisFAERS: 1US FAERS
173AsphyxiaFAERS: 1US FAERS
174AsterixisFAERS: 1US FAERS
175AtaxiaFAERS: 1US FAERS
176Bipolar DisorderFAERS: 1US FAERS
177BlindnessFAERS: 1US FAERS
178Blood alkaline phosphatase increasedFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
179Blood alkaline phosphataseFAERS: 1US FAERS
180Blood amylase increasedFAERS: 1US FAERS
181Blood glucose increasedFAERS: 1US FAERS
182Blood potassium decreasedFAERS: 1US FAERS
183Blood pressure fluctuationFAERS: 1US FAERS
184Blood pressure inadequately controlledFAERS: 1US FAERS
185Blood urine presentFAERS: 1US FAERS
186Cardiac HypertrophyFAERS: 1US FAERS
187Carotid artery occlusionFAERS: 1US FAERS
188Chest discomfortFAERS: 1US FAERS
189ChillsFAERS: 1US FAERS
190ChokingFAERS: 1US FAERS
191ChromaturiaFAERS: 1US FAERS
192Cognitive deteriorationFAERS: 1US FAERS
193Compression fractureFAERS: 1US FAERS
194Conduct DisorderFAERS: 1US FAERS
195Consciousness fluctuatingFAERS: 1US FAERS
196Cortical laminar necrosisFAERS: 1US FAERS
197CryingFAERS: 1US FAERS
198CystFAERS: 1US FAERS
199Delusional disorder, unspecified typeFAERS: 1US FAERS
200Depressed moodFAERS: 1US FAERS
201Diabetes MellitusFAERS: 1US FAERS
202Diabetes mellitus inadequate controlFAERS: 1US FAERS
203Diet refusalFAERS: 1US FAERS
204Disease complicationFAERS: 1US FAERS
205Drug abuseFAERS: 1US FAERS
206Drug level increasedFAERS: 1US FAERS
207Drug toxicityFAERS: 1US FAERS
208Duodenal UlcerFAERS: 1US FAERS
209Duodenal ulcer perforationFAERS: 1US FAERS
210Dyspnoea exacerbatedFAERS: 1US FAERS
211Ejection Fraction DecreasedFAERS: 1US FAERS
212Electrocardiogram ST-T segment abnormalFAERS: 1US FAERS
213Electrocardiogram abnormalFAERS: 1US FAERS
214Electrocardiogram changeFAERS: 1US FAERS
215Electroencephalogram abnormalFAERS: 1US FAERS
216Electrolyte imbalanceFAERS: 1US FAERS
217Emotional disorderFAERS: 1US FAERS
218EncephalitisFAERS: 1US FAERS
219EnteritisFAERS: 1US FAERS
220EpistaxisFAERS: 1US FAERS
221ExcitabilityFAERS: 1US FAERS
222Fistula dischargeFAERS: 1US FAERS
223Foaming at mouthFAERS: 1US FAERS
224Frontotemporal dementiaFAERS: 1US FAERS
225GastrectomyFAERS: 1US FAERS
226Gastric ulcer helicobacterFAERS: 1US FAERS
227GastroenteritisFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
228Gastrointestinal hypermotilityFAERS: 1US FAERS
229Gastrointestinal sounds abnormalFAERS: 1US FAERS
230GranulomaFAERS: 1US FAERS
231HemiparesisFAERS: 1US FAERS
232Hepatic Vein ThrombosisFAERS: 1US FAERS
233HydrocephalusFAERS: 1US FAERS
234Hypertensive heart diseaseFAERS: 1US FAERS
235HypervigilanceFAERS: 1US FAERS
236HypophagiaFAERS: 1US FAERS
237HyporeflexiaFAERS: 1US FAERS
238HypoxiaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
239IncoherentFAERS: 1US FAERS
240Incorrect route of product administrationFAERS: 1US FAERS
241Increased upper airway secretionFAERS: 1US FAERS
242InfectionFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
243Infective spondylitisFAERS: 1US FAERS
244InflammationFAERS: 1US FAERS
245Intentional self-injuryFAERS: 1US FAERS
246Intercepted medication errorFAERS: 1US FAERS
247Intestinal ObstructionFAERS: 1US FAERS
248Joint injuryFAERS: 1US FAERS
249LabyrinthitisFAERS: 1US FAERS
250Large intestine perforationFAERS: 1US FAERS
251LethargyFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
252Lipase increasedFAERS: 1US FAERS
253LymphomaFAERS: 1US FAERS
254MeningorrhagiaFAERS: 1US FAERS
255Muscle CrampFAERS: 1US FAERS
256Muscle SpasticityFAERS: 1US FAERS
257MyalgiaFAERS: 1US FAERS
258Myasthenia GravisFAERS: 1US FAERS
259Myocardial fibrosisFAERS: 1US FAERS
260NarcolepsyFAERS: 1US FAERS
261NasopharyngitisFAERS: 1US FAERS
262NeuropathyFAERS: 1US FAERS
263NeutropeniaFAERS: 1US FAERS
264No adverse drug reactionFAERS: 1US FAERS
265Optic NeuritisFAERS: 1US FAERS
266Oral infectionFAERS: 1US FAERS
267OsteoporosisFAERS: 1US FAERS
268PallorFAERS: 1US FAERS
269Pancreatic CystFAERS: 1US FAERS
270Pancreatic carcinomaFAERS: 1US FAERS
271ParanoiaFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
272Personality ChangeFAERS: 1US FAERS
273Physical deconditioningFAERS: 1US FAERS
274PoisoningFAERS: 1US FAERS
275Polymyalgia RheumaticaFAERS: 1US FAERS
276Poor personal hygieneFAERS: 1US FAERS
277Poor quality sleepFAERS: 1US FAERS
278Portal Vein ThrombosisFAERS: 1US FAERS
279Post procedural complicationFAERS: 1US FAERS
280PresyncopeFAERS: 1US FAERS
281Product availability issueFAERS: 1US FAERS
282Product name confusionFAERS: 1US FAERS
283Product packaging issueFAERS: 1US FAERS
284Product use complaintFAERS: 1US FAERS
285Productive CoughFAERS: 1US FAERS
286Progressive supranuclear palsyFAERS: 1US FAERS
287PsittacosisFAERS: 1US FAERS
288PsoriasisFAERS: 1US FAERS
289Pulmonary arterial hypertensionFAERS: 1US FAERS
290Pulmonary arterial pressure increasedFAERS: 1US FAERS
291Pulmonary congestionFAERS: 1US FAERS
292Renal cystFAERS: 1US FAERS
293Renal tubular acidosisFAERS: 1US FAERS
294RetchingFAERS: 1US FAERS
295SclerodermaFAERS: 1US FAERS
296ScreamingFAERS: 1US FAERS
297Sedation complicationFAERS: 1US FAERS
298Sexual DysfunctionFAERS: 1US FAERS
299SigmoiditisFAERS: 1US FAERS
300Silent myocardial infarctionFAERS: 1US FAERS
301Simple Partial SeizuresFAERS: 1US FAERS
302Sinus TachycardiaFAERS: 1US FAERS
303Spinal column injuryFAERS: 1US FAERS
304Spinal column stenosisFAERS: 1US FAERS
305SpondylitisFAERS: 1US FAERS
306Status EpilepticusFAERS: 1US FAERS
307Suicide attemptFAERS: 1US FAERS
308Systolic hypertensionFAERS: 1US FAERS
309Temporal ArteritisFAERS: 1US FAERS
310Thermal burnFAERS: 1US FAERS
311Tongue blisteringFAERS: 1US FAERS
312Toxicity to various agentsFAERS: 1US FAERS
313TracheobronchitisFAERS: 1US FAERS
314Trifascicular blockFAERS: 1US FAERS
315VIIth nerve paralysisFAERS: 1US FAERS
316Water IntoxicationFAERS: 1US FAERS
317cancer surgeryFAERS: 1US FAERS
318nervous system disorderFAERS: 1US FAERS
319ApathyCanada Vigilance: 1Canada Vigilance
320AphasiaCanada Vigilance: 2Canada Vigilance
321DiverticulitisCanada Vigilance: 1Canada Vigilance
322DysarthriaCanada Vigilance: 2Canada Vigilance
323DyspepsiaCanada Vigilance: 1Canada Vigilance
324HemiplegiaCanada Vigilance: 1Canada Vigilance
325HypokinesiaCanada Vigilance: 1Canada Vigilance
326Loss of personal independence in daily activitiesCanada Vigilance: 1Canada Vigilance
327Mental impairmentCanada Vigilance: 3Canada Vigilance
328Night sweatsCanada Vigilance: 1Canada Vigilance
329PainCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.